2015 Executive Officer Compensation Arrangements
EX-10.3 3 jazzq12015ex103.htm JAZZ PHARMACEUTICALS PLC 2015 EXECUTIVE OFFICER COMPENSATION ARRANGEMENTS JAZZ Q1 2015 EX 10.3
Exhibit 10.3
2015 Executive Officer Compensation Arrangements
Executive Officer | Base Salary Rate(1) | Target Bonus as % of Annual Base Salary Rate(2) |
Bruce C. Cozadd Chairman and Chief Executive Officer | $875,000 | 100 |
Russell J. Cox Executive Vice President and Chief Operating Officer | $550,000 | 55 |
Suzanne Sawochka Hooper Executive Vice President and General Counsel | $500,000 | 55 |
Matthew P. Young Executive Vice President and Chief Financial Officer | $475,000 | 55 |
Iain McGill Senior Vice President, Jazz Pharmaceuticals Europe and Rest of World | £240,000 | 45 |
Michael P. Miller Senior Vice President, U.S. Commercial | $430,000 | 45 |
Karen Smith, M.D., Ph.D. Global Head of Research & Development and Chief Medical Officer | $475,000 | 45 |
Paul Treacy Senior Vice President, Technical Operations | €250,800 | 45 |
Karen J. Wilson Senior Vice President, Finance and Principal Accounting Officer | $310,000 | 45 |
(1) | 2015 Base salary rates generally effective by March 1, 2015. Dr. Smith’s base salary rate is effective beginning on April 13, 2015, the commencement date of her employment. |
(2) | Target bonus percentage for each officer is based on his or her position and/or responsibility level as provided in Jazz Pharmaceuticals plc’s cash bonus plans. |
